Health Care & Life Sciences » Biotechnology | BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. | Key People and Executives

Mark Wegman
Director
Toby Wegman
Director
Jyrki Pekka Sakari Mattila
Independent Director
Jennifer M. Chao
Independent Director
Paul A. Gitman
Independent Director
Michael Schamroth
Independent Director
Thomas L. Wegman
President, CEO & Principal Financial Officer
Mark Wegman
Director
Toby Wegman
Director
Jyrki Pekka Sakari Mattila
Independent Director
Jennifer M. Chao
Independent Director
Paul A. Gitman
Independent Director
Michael Schamroth
Independent Director

About BioSpecifics Technologies

View Profile
Address
35 Wilbur Street
Lynbrook New York 11563
United States
Employees -
Website http://www.biospecifics.com
Updated 07/08/2019
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY.